Global Wet Granulation Equipment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Wet Granulation Equipment Market Overview

The Wet Granulation Equipment Market was valued at USD 4.90 billion in 2025 and is projected to reach USD 7.86 billion by 2033, growing at a CAGR of 6.10% from 2026 to 2033. The market is witnessing steady growth driven by increasing pharmaceutical manufacturing activities, rising demand for high-quality granule processing systems, and growing adoption of advanced solid dosage production technologies across pharmaceutical, nutraceutical, food, and chemical industries.

The expansion of the pharmaceutical sector worldwide, combined with stringent regulatory requirements for product uniformity, drug stability, and process efficiency, is encouraging manufacturers to invest in advanced wet granulation systems. High-shear granulators, fluid bed granulators, and automated processing equipment are increasingly replacing conventional batch processing methods due to their ability to improve mixing consistency, reduce production time, and enhance scalability. In addition, technological advancements in automation, continuous manufacturing, and process analytical technology (PAT) integration are further supporting market growth by enabling precise control, improved operational efficiency, and reduced manufacturing costs.

Key Market Trends & Insights

• North America dominated the Wet Granulation Equipment Market with the largest revenue share of 35.12% in 2025, supported by strong pharmaceutical manufacturing infrastructure, high adoption of advanced processing technologies, and significant investments in drug production facilities.
• The Rapid Mixer Granulator segment led the market with a 46.3% share in 2025, driven by strong adoption in pharmaceutical tablet manufacturing and superior ability to ensure uniform mixing and fast granule formation.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 7.1% from 2026 to 2033, fueled by expanding pharmaceutical production, increasing healthcare expenditures, and rising investments in manufacturing facilities across China, India, and Southeast Asia.
• Fluidized Bed Granulator are the fastest-growing product type, projected to register a CAGR of 6.8%, reflecting the surge in demand for energy-efficient and multifunctional processing systems.
• The Automatic segment dominated the operation mode category with a 58.91% revenue share in 2025, led by high precision, reduced human intervention, and strong suitability for large-scale pharmaceutical production.
• Commercial Scale Manufacturing accounted for 52.1% of the market, preferred by large-volume pharmaceutical production and rising demand for standardized oral solid dosage forms.
• The Pilot Batch Scaling segment is the fastest-growing application category, with a CAGR of 7.3%, driven by rising investment in drug development and formulation optimization.

Market Size & Forecast

• Global Market Value (2025): USD 4.90 Billion
• Expected Market Value (2033): USD 7.86 Billion
• Forecast CAGR (2026–2033): 6.10%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia Pacific

Report Scope and Wet Granulation Equipment Market Segmentation

Wet Granulation Equipment Market Trends

Trend: Rising Adoption of Continuous Manufacturing & Process Automation

Pharmaceutical manufacturers are increasingly adopting advanced wet granulation equipment to improve production efficiency, ensure batch consistency, and reduce material wastage during oral solid dosage manufacturing. The integration of automated control systems and process analytical technology enables precise monitoring of granule properties, moisture levels, and mixing parameters in real time. Contract manufacturing organizations and nutraceutical producers are similarly investing in continuous wet granulation systems to support scalable production requirements, while smart manufacturing technologies improve operational flexibility and regulatory compliance across high-volume manufacturing environments.

For instance, in March 2024, GEA Group expanded its pharmaceutical processing portfolio with advanced continuous granulation solutions designed to improve production scalability and real-time quality monitoring capabilities.

Wet Granulation Equipment Market Dynamics

Key Market Driver: Growing Demand for Pharmaceutical Solid Dosage Manufacturing

The rapid expansion of pharmaceutical manufacturing and increasing demand for tablets and capsules have created substantial demand for advanced wet granulation equipment capable of improving powder flow, granule consistency, and product stability across large-scale production environments. Pharmaceutical companies, contract manufacturers, and nutraceutical producers are deploying automated granulation systems as a core component of modern production facilities, reducing processing variability, accelerating manufacturing cycles, and improving compliance with stringent pharmaceutical quality standards. For instance, in February 2024, Syntegon Technology introduced upgraded pharmaceutical granulation technologies focused on improving production efficiency and supporting continuous oral solid dosage manufacturing applications.

Key Restraint/Challenge: High Capital Investment and Equipment Maintenance Costs

A significant restraint in the Wet Granulation Equipment Market is the high upfront investment required for advanced processing systems. Modern granulation platforms integrate automated control technologies, high-shear mixing systems, fluid bed processing units, and process monitoring software, demanding substantial expenditure for procurement, installation, validation, and ongoing maintenance. The total operational cost further extends to equipment upgrades, energy consumption, and technical servicing, limiting adoption among small pharmaceutical manufacturers and regional nutraceutical production facilities.

For instance, in January 2024, Freund Corporation highlighted increasing operational and maintenance requirements associated with advanced pharmaceutical granulation systems developed for large-scale continuous manufacturing operations.

Key Market Opportunity: Expansion of Continuous Manufacturing and Smart Processing Technologies

The integration of continuous manufacturing technologies in pharmaceutical processing presents a significant market opportunity. Smart wet granulation systems can improve process efficiency, enable real-time quality assurance, and support scalable production of complex oral solid dosage formulations. The development of automated monitoring platforms and data-driven manufacturing environments is further improving operational productivity, opening growth opportunities across pharmaceutical and nutraceutical production facilities in Asia-Pacific, Latin America, and the Middle East.

For instance, in April 2024, Glatt GmbH expanded its continuous processing solutions portfolio with advanced wet granulation technologies designed for automated pharmaceutical manufacturing and enhanced process optimization.

Wet Granulation Equipment Market Scope

The wet granulation equipment market is segmented on the basis of product type, operation mode, application, and end-users.

• By Product Type

On the basis of product type, the Wet Granulation Equipment Market is segmented into rapid mixer granulator, fluidized bed granulator, and others. The Rapid Mixer Granulator segment dominated the market with a 46.3% share in 2025, driven by its strong adoption in pharmaceutical tablet manufacturing and superior ability to ensure uniform mixing and fast granule formation. These systems are widely preferred for large-scale production due to their high throughput and consistent output quality. They significantly reduce processing time compared to conventional methods, improving overall manufacturing efficiency. Increasing demand for solid oral dosage forms is further strengthening adoption across global pharmaceutical facilities. Their compatibility with automated systems enhances production reliability and regulatory compliance. Continuous upgrades in design and cleaning efficiency are also supporting segment dominance.

The Fluidized Bed Granulator segment is expected to witness the fastest growth with a CAGR of 6.8% from 2026 to 2033, driven by rising demand for energy-efficient and multifunctional processing systems. These machines combine granulation, drying, and coating functions, making them highly efficient for modern pharmaceutical production. They are increasingly used in applications requiring precise particle size distribution and improved product uniformity. Growing adoption of continuous manufacturing technologies is further accelerating demand. Pharmaceutical and nutraceutical manufacturers are increasingly shifting toward these systems for process optimization. Their ability to reduce batch variability and improve scalability is a key growth driver.

• By Operation Mode

On the basis of operation mode, the Wet Granulation Equipment Market is segmented into automatic, semi-automatic, and manual systems. The Automatic segment dominated the market with a 58.9% share in 2025, owing to its high precision, reduced human intervention, and strong suitability for large-scale pharmaceutical production. These systems enable real-time monitoring and tight control over process parameters such as mixing speed and moisture content. They are widely used in regulated industries where consistency and compliance are critical. Integration with digital manufacturing systems further enhances operational efficiency. Automation also reduces labor costs and minimizes production errors. Strong demand from global pharmaceutical manufacturers continues to reinforce this segment’s leadership.

The Semi-Automatic segment is expected to witness the fastest growth with a CAGR of 7.0% from 2026 to 2033, driven by increasing adoption among mid-sized manufacturers and contract production facilities. These systems offer a balanced combination of affordability and operational control. They are particularly popular in emerging economies due to lower capital requirements compared to fully automated systems. Growing expansion of generic drug manufacturing is significantly boosting demand. Their flexibility in handling multiple batch sizes supports diverse production needs. Rising industrialization in Asia-Pacific and Latin America is further accelerating adoption.

• By Application

On the basis of application, the Wet Granulation Equipment Market is segmented into laboratory experiments, pilot batch scaling, commercial scale manufacturing, and others. The Commercial Scale Manufacturing segment dominated the market with a 52.1% share in 2025, driven by large-volume pharmaceutical production and rising demand for standardized oral solid dosage forms. These systems are essential for ensuring consistent product quality in high-output manufacturing environments. Pharmaceutical companies rely heavily on wet granulation equipment to meet strict regulatory standards. Increasing consumption of prescription and generic drugs further strengthens demand. Automation integration in production facilities is also enhancing efficiency. Continuous expansion of global pharmaceutical manufacturing infrastructure supports long-term dominance.

The Pilot Batch Scaling segment is expected to witness the fastest growth with a CAGR of 7.3% from 2026 to 2033, driven by rising investment in drug development and formulation optimization. These systems are widely used to evaluate product performance before full-scale production. Pharmaceutical companies and CROs are increasingly adopting pilot-scale equipment to reduce development risks. Growing focus on faster time-to-market for new drugs is boosting demand. They also help in optimizing cost and improving production efficiency. Expanding R&D activities in emerging markets are further supporting growth.

• By End-Users

On the basis of end-users, the Wet Granulation Equipment Market is segmented into pharmaceutical research laboratories, pharmaceutical production plants, contract research and manufacturing organizations, academic and research institutes, and others. The Pharmaceutical Production Plants segment dominated the market with a 48.6% share in 2025, driven by high-volume drug manufacturing and increasing demand for consistent solid dosage production. These facilities require advanced wet granulation systems for efficiency, scalability, and regulatory compliance. Rising global healthcare demand and chronic disease prevalence are further supporting growth. Strong investments in pharmaceutical infrastructure also reinforce segment leadership. Automation and process optimization are widely adopted in production environments. The need for large-scale, high-quality output continues to drive dominance.

The Contract Research and Manufacturing Organizations (CROs/CMOs) segment is expected to witness the fastest growth with a CAGR of 7.5% from 2026 to 2033, driven by increasing outsourcing of pharmaceutical production and R&D activities. These organizations require flexible, high-performance equipment to meet diverse client requirements. Growing demand for cost-efficient drug development solutions is accelerating adoption. CROs and CMOs are investing heavily in advanced manufacturing technologies. Expansion of global pharmaceutical outsourcing networks further supports growth. Their role in accelerating drug development timelines is a key market driver.

Wet Granulation Equipment Market Regional Analysis

North America dominated the Wet Granulation Equipment Market with the largest revenue share of 35.12% in 2025, supported by strong pharmaceutical manufacturing infrastructure, high adoption of advanced processing technologies, and significant investments in drug production facilities. The region also benefits from strict regulatory standards for drug quality, widespread use of automated manufacturing systems, and continuous investment in pharmaceutical R&D and production capacity expansion. Increasing demand for generic drugs, biologics supporting formulations, and advanced oral solid dosage manufacturing continues to strengthen North America’s leadership position in the global market.

U.S. Wet Granulation Equipment Market Insight

The U.S. wet granulation equipment market is witnessing strong growth due to rising pharmaceutical manufacturing investments, expanding contract manufacturing activities, and increasing demand for advanced solid dosage production systems. The country’s well-established pharmaceutical ecosystem, along with strong presence of leading drug manufacturers and technology providers, is driving adoption of high-shear and automated granulation systems. In addition, strict FDA regulations on drug quality and consistency are encouraging manufacturers to upgrade legacy production systems. Growing focus on continuous manufacturing, process automation, and R&D in formulation development continues to strengthen market demand across pharmaceutical production facilities and research organizations.

Europe Wet Granulation Equipment Market Insight

The Europe wet granulation equipment market remains a major contributor to global revenue, driven by strong pharmaceutical production capabilities, high regulatory compliance standards, and advanced manufacturing infrastructure. The widespread use of high-precision granulation systems in drug formulation, nutraceutical production, and contract manufacturing is supporting market expansion across the region. Increasing investments in continuous manufacturing technologies and sustainable production processes are further enhancing equipment adoption. Additionally, strong focus on quality assurance, process validation, and advanced automation continues to reinforce Europe’s position as a key hub for pharmaceutical equipment innovation.

U.K. Wet Granulation Equipment Market Insight

The U.K. wet granulation equipment market is experiencing steady growth, supported by rising pharmaceutical R&D activities, expansion of contract manufacturing organizations, and increasing demand for flexible production systems. Growing investments in advanced drug formulation technologies and pilot-scale manufacturing facilities are contributing to market expansion. The integration of automation, process analytical technology, and digital monitoring systems is improving production efficiency and compliance standards. Furthermore, strong academic-industry collaboration and focus on innovative drug development are positioning the U.K. as an important contributor to pharmaceutical equipment advancement in Europe.

Germany Wet Granulation Equipment Market Insight

The Germany wet granulation equipment market is expanding steadily due to the country’s strong pharmaceutical manufacturing base, advanced engineering capabilities, and increasing adoption of high-efficiency production systems. Pharmaceutical companies and contract manufacturers are increasingly deploying automated granulation equipment to improve process consistency and operational efficiency. Growing emphasis on continuous manufacturing, energy-efficient systems, and precision engineering is further driving market growth. In addition, strong regulatory environment and focus on high-quality drug production continue to support widespread adoption of advanced wet granulation technologies in Germany.

Asia-Pacific Wet Granulation Equipment Market Insight

The Asia-Pacific wet granulation equipment market is expected to witness rapid growth, driven by expanding pharmaceutical manufacturing, rising healthcare demand, and increasing investments in production infrastructure across countries such as China, India, and Japan. Growing adoption of cost-effective manufacturing technologies and increasing presence of generic drug producers are supporting regional expansion. Rising focus on improving production efficiency, scalability, and regulatory compliance is further accelerating equipment adoption. Additionally, increasing contract manufacturing activities and rapid industrialization are positioning Asia-Pacific as the fastest-growing region in the global market.

Japan Wet Granulation Equipment Market Insight

The Japan wet granulation equipment market is witnessing consistent growth due to strong pharmaceutical innovation, advanced manufacturing standards, and increasing adoption of high-precision production technologies. Pharmaceutical companies and research institutes are increasingly utilizing automated granulation systems for improved formulation development and quality control. Growing integration of digital monitoring, automation, and process optimization technologies is enhancing manufacturing efficiency. Moreover, Japan’s strong focus on high-quality drug production and continuous process improvement is further supporting steady market growth.

China Wet Granulation Equipment Market Insight

The China wet granulation equipment market is growing rapidly, driven by expanding pharmaceutical production capacity, increasing demand for generic medicines, and strong government support for healthcare infrastructure development. Rising investments in modern manufacturing facilities and growing adoption of automated and continuous granulation systems are significantly boosting market demand. In addition, increasing focus on drug quality standards, technological advancements, and expansion of domestic pharmaceutical companies are positioning China as one of the fastest-growing markets globally.

Wet Granulation Equipment Market Share

The wet granulation equipment industry is primarily led by well-established companies, including:

• GEA Group (Germany)
• Syntegon Technology (Germany)
• Glatt GmbH (Germany)
• B. Bohle Maschinen + Verfahren GmbH (Germany)
• Freund Corporation (Japan)
• Frewitt SA (Switzerland)
• Bühler Group (Switzerland)
• IMA Group (Italy)
• ACG Worldwide (India)
• Cadmach Machinery Co. Pvt. Ltd. (India)
• Fette Compacting GmbH (Germany)
• Diosna Dierks & Söhne GmbH (Germany)
• Bosch Packaging Technology (Germany)
• Sturtevant Inc. (U.S.)
• Scott Equipment Company (U.S.)
• Charles Ross & Son Company (U.S.)
• PerMix Tec Co. Ltd. (China)
• Yenchen Machinery Co., Ltd. (Taiwan)
• Key International, Inc. (U.S.)

Latest Developments in Wet Granulation Equipment Market

• In September 2025, Freund Corporation announced advancements in its high-shear wet granulation systems, focusing on improved mixing uniformity, reduced processing time, and enhanced scalability for pharmaceutical solid dosage manufacturing. The development supports integration with automated production lines and digital monitoring systems to ensure consistent batch quality. It also enhances equipment reliability for large-scale manufacturing environments. This upgrade reflects growing industry demand for efficient and compliant granulation technologies. It further strengthens Freund’s position in global pharmaceutical processing equipment markets
• In April 2024, GEA Group expanded its pharmaceutical processing solutions with upgraded wet granulation and fluid bed technologies designed to support continuous manufacturing and improve process efficiency in oral solid dosage production. The enhancement focuses on integrating automation and process analytical technology for real-time quality control and improved batch consistency. It also supports scalable manufacturing across pharmaceutical and nutraceutical applications. The development aligns with industry trends toward smart and connected production systems. It reinforces GEA’s leadership in advanced pharmaceutical processing equipment
• In November 2023, Syntegon Technology introduced enhanced pharmaceutical processing systems aimed at improving wet granulation efficiency and supporting integrated solid dosage manufacturing workflows. The development emphasizes automation, reduced process variability, and seamless equipment integration across production lines. It also improves operational efficiency and regulatory compliance in pharmaceutical manufacturing environments. The upgrade supports growing demand for continuous and digitalized production systems. It strengthens Syntegon’s capabilities in pharmaceutical process innovation
• In June 2022, Glatt GmbH advanced its fluid bed and wet granulation technologies with a focus on improved energy efficiency, product uniformity, and scalable manufacturing solutions. The development supports both batch and continuous production environments with enhanced process control capabilities. It also enables better consistency in pharmaceutical and nutraceutical formulations. The innovation reflects growing demand for integrated and automated processing systems. It reinforces Glatt’s strong position in pharmaceutical granulation technology
• In March 2021, L.B. Bohle Maschinen + Verfahren GmbH introduced developments in continuous wet granulation systems aimed at improving scalability, reducing processing time, and enhancing product consistency in pharmaceutical manufacturing. The innovation supports transition from traditional batch processing to continuous production models. It also integrates advanced process control for improved reproducibility and efficiency. The system is designed for high-performance solid dosage manufacturing environments. It highlights the industry shift toward continuous pharmaceutical production technologies

SKU-55349